Disease
|
Drug/Important Bio-Agent (IBA)
2 | Biomarkers (Surrogate Marker)IBA
03/2013
-
10/2010 |
1 | Alanine Transaminase (SGPT)IBA
03/2013 |
1 | Pyruvic Acid (Pyruvate)IBA
03/2013 |
1 | NitrogenIBA
03/2013 |
1 | Glutamic Acid (Glutamate)FDA Link
03/2013 |
1 | Alanine (L-Alanine)FDA Link
03/2013 |
1 | carbogenIBA
01/2012 |
1 | TaurineFDA Link
10/2010 |
1 | LipidsIBA
10/2010 |
1 | Glycine (Aminoacetic Acid)FDA LinkGeneric
10/2010 |
1 | Phosphorylcholine (Phosphocholine)IBA
10/2010 |
1 | mirdametinibIBA
04/2010 |
1 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2010 |
1 | LeptinIBA
11/2009 |
1 | Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
05/2009 |
1 | Carmustine (FIVB)FDA Link
07/2006 |
1 | Illicit Drugs (Recreational Drugs)IBA
05/2005 |
1 | N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
05/2005 |
1 | Mitochondrial Uncoupling ProteinsIBA
05/2005 |
1 | Creatine Kinase (Creatine Phosphokinase)IBA
05/2005 |
1 | Indicators and Reagents (Reagents)IBA
03/2005 |
1 | ethylisopropylamiloride (EIPA)IBA
03/2005 |
1 | thulium(III) 1,4,7,10- tetramethyl- 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetraacetateIBA
02/2005 |
1 | Sodium-Hydrogen ExchangersIBA
02/2004 |
1 | SodiumIBA
02/2004 |
1 | thulium- 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetraacetateIBA
05/2002 |
1 | Lanthanoid Series Elements (Lanthanides)IBA
05/2002 |
|
Therapy/Procedure
|